Bvf Inc Generation Bio Co. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.66 - $6.77 $947,661 - $1.75 Million	-258,924 Reduced 71.56%	102,900 $404,000
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $5.59 Million - $9.96 Million	-1,194,208 Reduced 76.75%	361,824 $1.92 Million
Q2 2022 Aug 15, 2022	SELL	$4.87 - $9.41 $6.07 Million - $11.7 Million	-1,246,918 Reduced 44.49%	1,556,032 $10.3 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $7.76 $10.9 Million - $20.3 Million	2,613,900 Added 1382.65%	2,802,950 $20.6 Million
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $1.13 Million - $4.72 Million	189,050 New	189,050 $1.34 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $80.8M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.